Logo image of ADPT

ADAPTIVE BIOTECHNOLOGIES (ADPT) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ADPT - US00650F1093 - Common Stock

14.71 USD
-0.04 (-0.27%)
Last: 12/8/2025, 1:22:28 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ADPT revenue by date.ADPT revenue by date.
185.3M
20.09%
170.276M
-8.11%
178.957M
5.10%
269.89M
50.81%
273.04M
1.17%
332.53M
21.79%
397.94M
19.67%
484.91M
21.86%
569.16M
17.37%
EBITDA
YoY % growth
ADPT ebitda by date.ADPT ebitda by date.
-177.7M
8.87%
-179.375M
-0.94%
-136.088M
24.13%
-13.432M
90.13%
-36.454M
-171.40%
17.176M
147.12%
87.72M
410.71%
42.228M
-51.86%
N/A
EBIT
YoY % growth
ADPT ebit by date.ADPT ebit by date.
-198.6M
4.98%
-201.606M
-1.51%
-155.344M
22.95%
-74.132M
52.28%
-90.497M
-22.08%
-55.968M
38.15%
-22.406M
59.97%
-31.518M
-40.67%
7.14M
122.65%
Operating Margin
ADPT operating margin by date.ADPT operating margin by date.
-107.18%-118.40%-86.81%-27.47%-33.14%-16.83%-5.63%-6.50%1.25%
EPS
YoY % growth
ADPT eps by date.ADPT eps by date.
-1.41
4.08%
-1.38
2.13%
-1.09
21.01%
-0.50
54.26%
-0.59
-17.65%
-0.37
37.39%
-0.15
60.19%
-0.19
-32.59%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.19
19.07%
-0.17
13.94%
-0.15
13.75%
-0.14
-333.75%
-0.13
31.51%
-0.06
64.44%
-0.14
2.61%
-0.09
34.55%
-0.06
52.00%
Revenue
Q2Q % growth
60.477M
27.43%
60.245M
14.88%
67.148M
14.04%
70.808M
-24.65%
73.828M
22.08%
73.95M
22.75%
88.128M
31.24%
80.886M
14.23%
83.334M
12.88%
EBITDA
Q2Q % growth
-7.825M
45.27%
-9.228M
62.90%
-5.059M
67.99%
3.998M
-83.29%
-1.122M
85.66%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-26.704M
21.46%
-26.095M
11.85%
-21.99M
12.17%
-21.146M
-305.50%
-16.928M
36.61%
-8.16M
68.73%
-21.114M
3.98%
-13.362M
36.81%
-8.874M
47.58%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.06
127.27%
-0.150.21140.22%
Q2 2025
Q2Q % growth
-0.17
45.16%
-0.240.0730.19%
Q1 2025
Q2Q % growth
-0.20
39.39%
-0.300.1032.96%
Q4 2024
Q2Q % growth
-0.23
23.33%
-0.260.0312.00%
Q3 2024
Q2Q % growth
-0.22
37.14%
-0.290.0724.98%
Q2 2024
Q2Q % growth
-0.31
6.06%
-0.340.038.94%
Q1 2024
Q2Q % growth
-0.33
17.50%
-0.350.025.24%
Q4 2023
Q2Q % growth
-0.30
-7.14%
-0.340.0411.21%
Q3 2023
Q2Q % growth
-0.35
-9.37%
-0.350.00-1.25%
Q2 2023
Q2Q % growth
-0.33
10.81%
-0.350.026.66%
Q1 2023
Q2Q % growth
-0.40
9.09%
-0.38-0.02-4.08%
Q4 2022
Q2Q % growth
-0.28
34.88%
-0.350.0720.75%
Q3 2022
Q2Q % growth
-0.32
20.00%
-0.380.0616.56%
Q2 2022
Q2Q % growth
-0.37
-5.71%
-0.440.0715.64%
Q1 2022
Q2Q % growth
-0.44
-51.72%
-0.470.035.93%
Q4 2021
Q2Q % growth
-0.43
-30.30%
-0.460.036.61%
Q3 2021
Q2Q % growth
-0.40
-48.15%
-0.430.036.91%
Q2 2021
Q2Q % growth
-0.35
-34.62%
-0.440.0919.67%
Q1 2021
Q2Q % growth
-0.29
-16.00%
-0.420.1330.41%
Q4 2020
Q2Q % growth
-0.33
-94.12%
-0.30-0.03-10.47%
Q3 2020
Q2Q % growth
-0.27
-145.45%
-0.290.026.89%
Q2 2020
Q2Q % growth
-0.26
78.86%
-0.290.0310.56%
Q1 2020
Q2Q % growth
-0.25 -0.21-0.04-19.85%
Q4 2019
Q2Q % growth
-0.17 -0.200.0315.82%
Q3 2019
Q2Q % growth
-0.11 -0.240.1354.43%
Q2 2019
Q2Q % growth
-1.23 -0.14-1.09-787.79%
ADPT Yearly EPS VS EstimatesADPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -0.5 -1 -1.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
93.973M
102.38%
65.936M28.037M42.52%
Q2 2025
Q2Q % growth
58.879M
36.33%
50.388M8.491M16.85%
Q1 2025
Q2Q % growth
52.443M
25.24%
43.532M8.911M20.47%
Q4 2024
Q2Q % growth
47.459M
3.66%
46.955M504K1.07%
Q3 2024
Q2Q % growth
46.435M
22.46%
41.012M5.423M13.22%
Q2 2024
Q2Q % growth
43.19M
-11.72%
39.438M3.752M9.51%
Q1 2024
Q2Q % growth
41.873M
11.23%
39.56M2.313M5.85%
Q4 2023
Q2Q % growth
45.784M
-17.06%
49.427M-3.643M-7.37%
Q3 2023
Q2Q % growth
37.919M
-20.72%
43.822M-5.903M-13.47%
Q2 2023
Q2Q % growth
48.926M
12.06%
45.785M3.141M6.86%
Q1 2023
Q2Q % growth
37.647M
-2.52%
37.547M100K0.27%
Q4 2022
Q2Q % growth
55.2M
45.53%
55.8M-600K-1.08%
Q3 2022
Q2Q % growth
47.83M
21.18%
48.991M-1.161M-2.37%
Q2 2022
Q2Q % growth
43.66M
13.37%
43.004M656K1.53%
Q1 2022
Q2Q % growth
38.62M
0.47%
38.464M156K0.41%
Q4 2021
Q2Q % growth
37.93M
25.64%
37.437M493K1.32%
Q3 2021
Q2Q % growth
39.47M
50.08%
37.368M2.102M5.63%
Q2 2021
Q2Q % growth
38.51M
83.47%
31.887M6.623M20.77%
Q1 2021
Q2Q % growth
38.44M
83.84%
28.302M10.138M35.82%
Q4 2020
Q2Q % growth
30.19M
24.70%
27.44M2.75M10.02%
Q3 2020
Q2Q % growth
26.3M
0.92%
24.055M2.245M9.33%
Q2 2020
Q2Q % growth
20.99M
-5.19%
19.176M1.814M9.46%
Q1 2020
Q2Q % growth
20.91M
65.04%
21.958M-1.048M-4.77%
Q4 2019
Q2Q % growth
24.21M 22.14M2.07M9.35%
Q3 2019
Q2Q % growth
26.06M 22.53M3.53M15.67%
Q2 2019
Q2Q % growth
22.14M 19.696M2.444M12.41%
ADPT Yearly Revenue VS EstimatesADPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -5.58% 27.99% 32.65%
Revenue-0.17% -6.1% 10.54% 13.6%